[ENSC] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ENSC] Ensysce Biosciences, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -53.14%
YoY- 21.22%
Quarter Report
ENSC's Result
ENSC's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 490 790 1,433 279 207 603 1,635 -55.31%
PBT -2,239 -2,192 -5,478 -9,856 -7,923 -951 -10,037 -63.31%
Tax -3 -364 -2,912 3,666 906 -3,867 8,018 -
NP -2,236 -1,828 -2,566 -13,521 -8,829 2,916 -10,037 -63.35%
Tax Rate - - - - - - - -
Total Cost 2,726 2,618 4,000 13,801 9,037 -2,313 11,672 -62.17%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -455.88 -231.53 -179.01 -4,840.31 -4,255.75 483.47 -613.78 -18.02%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.98 -1.73 -8.46 -84.13 -62.35 25.65 -100.00 -95.45%
EPS Diluted -0.98 -1.73 -8.46 -84.13 -62.35 25.65 -100.00 -95.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.